Dear Healthcare Professional Letters
Selected batches of Solu-Medrol 500mg/8ml injection (SIN04683P) do not contain Singapore Approved Packaging
Audiences
Healthcare professional
Product type
Therapeutic Products
20 March 2017
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Pfizer would like to inform healthcare professionals that three batches of Solu-Medrol® 500 mg/8ml (Batch: L41323, M68510 and R35679) are packed using Package insert (PI) not approved by the Singapore Health Sciences Authority (HSA). Healthcare professionals are advised to refer to the Singapore-approved (PI) for the current prescribing information. The PI within the box of Solu-Medrol® 500 mg/8 ml injection of the affected batches should be disregarded. Please refer to the letter for details.
Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of these letters can be found in the MOH Alert System, which is accessible via the Health Professionals Portal (HPP), a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://hpp.moh.gov.sg and follow the procedures below to access the MOH Alert system.
Step 1: Select your profession under ‘For Healthcare Professionals’.
Step 2: Click on ‘Useful links’.
Step 3: Click on ‘MOH Alert’ and log in via Singpass.
Step 4: Click on ‘Drug Alerts’ or ‘Med Device Alerts’ to view the DHCPLs.